These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 14191403

  • 1. AN EXPERIMENTAL THERAPEUTIC APPROACH TO L1210 LEUKEMIA IN MICE: COMBINED CHEMOTHERAPY AND CENTRAL NERVOUS SYSTEM IRRADIATION.
    JOHNSON RE.
    J Natl Cancer Inst; 1964 Jun; 32():1333-41. PubMed ID: 14191403
    [No Abstract] [Full Text] [Related]

  • 2. COMBINED SYSTEMIC CHEMOTHERAPY AND CENTRAL NERVOUS SYSTEM IRRADIATION IN THE TREATMENT OF MICE WITH L1210 LEUKEMIA.
    JOHNSON RE.
    Cancer Chemother Rep; 1963 Sep; 31():67-8. PubMed ID: 14066237
    [No Abstract] [Full Text] [Related]

  • 3. THERAPEUTIC AND IMMUNOLOGICAL RESPONSE OF MICE WITH MENINGEAL LEUKEMIA (L1210) TO CHALLENGE WITH AN ANTIFOLIC-RESISTANT VARIANT.
    CHIRIGOS MA, THOMAS LB, HUMPHREYS SR, GLYNN JP, GOLDIN A.
    Cancer Res; 1964 Apr; 24():409-15. PubMed ID: 14147814
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CHEMOTHERAPEUTIC EFFECTS ON MAMMALIAN TUMOR CELLS. I. MODIFICATION OF LEUKEMIA L1210 GROWTH KINETICS AND KARYOTYPE WITH AN ALKYLATING AGENT.
    JOHNSON RE, ZELEN M, KEMP NH.
    J Natl Cancer Inst; 1965 Feb; 34():277-90. PubMed ID: 14293793
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ.
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract] [Full Text] [Related]

  • 8. Investigation of the activity of cytoxan against leukemia L1210 in mice.
    VENDITTI JM, HUMPHREYS SR, GOLDIN A.
    Cancer Res; 1959 Oct; 19():986-95. PubMed ID: 13841661
    [No Abstract] [Full Text] [Related]

  • 9. HYDROXYMETHYLGLYOXAL BISGUANYLHYDRAZONE.
    LOO TL, DION RL, DAVIDSON JD, ADAMSON RH.
    J Med Chem; 1963 Nov; 6():819-20. PubMed ID: 14184964
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
    EVANS JS, BOSTWICK L, MENGEL GD.
    Biochem Pharmacol; 1964 Jul; 13():983-8. PubMed ID: 14201140
    [No Abstract] [Full Text] [Related]

  • 13. CHEMOTHERAPEUTIC EFFECTS ON MAMMALIAN TUMOR CELLS. II. BIOLOGIC AND CHROMOSOMAL INSTABILITY OF A CYCLOPHOSPHAMIDE-TREATED MURINE LEUKEMIA.
    JOHNSON RE, HARDY WG.
    Cancer Res; 1965 Jun; 25():604-8. PubMed ID: 14347546
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. THE EFFECT OF A PHTHALANILIDE DERIVATIVE ON LIPIDE METABOLISM IN L1210 LEUKEMIA CELLS.
    GELLHORN A, WAGNER M, RECHLER M, KOREN Z, BENJAMIN W.
    Cancer Res; 1964 Apr; 24():400-8. PubMed ID: 14147813
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HYDROXYUREA. A NEW TYPE OF POTENTIAL ANTITUMOR AGENT.
    STEARNS B, LOSEE KA, BERNSTEIN J.
    J Med Chem; 1963 Mar; 6():201. PubMed ID: 14188794
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.